Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.

Maze Therapeutics is a biotechnology firm used to focus on translating genetic insights into new medicines. The company's translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, functional genomics, and an array of drug discovery approaches. and it also reveals modifier genes that confer protection and provide a deeper understanding of the target biology and how these targets can be targeted with drug therapies, enabling patients with protection against diseases.

Maze Therapeutics

Director, Clinical Science

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient‚Äôs healthy tissue.

Janux Therapeutics develops immunotherapies that generate immune responses to prevent tumors and not affecting a patient‚Äôs healthy tissue. Janux technology targets all three stages of the anti-tumor immune response.

Janux Therapeutics

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

4D Molecular Therapeutics is a biotechnology company.The Company designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

4D Molecular Therapeutics

BeiGene is a life sciences, biotechnology company.

BeiGene is a clinical-stage Biopharma company focused on discovering and developing innovative, best-in-class, targeted and immuno-oncology drugs that address severe unmet medical needs in a variety of cancer indications.

BeiGene

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

Artiva Biotherapeutics is a private biotech company advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, for the treatment of hematologic cancers or solid tumors. It was founded on the understanding that NK cells hold enormous therapeutic potential as cancer therapies and the dedication and expertise to overcome technological barriers in the scaling and manufacturing of these cells. At Artiva, its mission is to deliver highly effective cell therapies that are also safe and immediately available and accessible to any cancer patient who stands to benefit. Artiva‚Äôs platform delivers scalability, quality, and cryopreservation to support a pipeline of safe, effective, versatile, and accessible product candidates.

Artiva Biotherapeutics

Verve Therapeutics is a genetic medicines company.

Verve Therapeutics is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. It has been purpose-built for the task ahead, with a team of experts in cardiovascular medicine, human genetics, gene editing, delivery technologies, drug development, and commercialization.

Location

Company Stage

Age of Data

Experience

Industry

Company

Director, Clinical Science

Maze Therapeutics

$240k - $293k

$240,000 - $293,000

Janux Therapeutics

$205k - $240k

$205,000 - $240,000

4D Molecular Therapeutics

$200k - $240k

$200,000 - $240,000

BeiGene

$171k - $231k

$171,000 - $231,000

Artiva Biotherapeutics

$199k - $210k

$199,000 - $210,000

Verve Therapeutics

N/A

N/A